Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL2213098

Clc1ccc(CN2CCC(NCCCCOc3ccc(-c4csc(N5CCCCC5)n4)cc3)CC2)cc1Cl.O=C(O)C(F)(F)F

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
UTS2R Q9UKP6 2/20 0.44
HRH1 P35367 2/20 0.41
CCR3 P51677 2/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
MCHR1 Q99705 3/20 0.41
MAOB P27338 2/20 0.40
CHEK2 O96017 1/20 0.40
HTR2A P28223 2/20 0.39
BCHE P06276 1/20 0.39
ACHE P22303 1/20 0.39
DRD2 P14416 1/20 0.39
DRD4 P21917 1/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
HRH3 Q9Y5N1 2/20 0.39
CHRM1 P11229 1/20 0.39
POLB P06746 1/20 0.39
HRH2 P25021 1/20 0.38
SLC2A1 P11166 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL6108505 1.00 UTS2R (0.44) UTS2RHRH1CCR3MEN1KMT2A
Trifluoroacetic Acid SCHEMBL2208294 0.99 UTS2R (0.44) UTS2RHRH1CCR3MEN1KMT2A
Trifluoroacetic Acid SCHEMBL2214532 0.94 AR (0.46) UTS2RHRH1CCR3MEN1KMT2A
Trifluoroacetic Acid SCHEMBL2210103 0.93 UTS2R (0.43) UTS2RHRH1CCR3MEN1KMT2A
Trifluoroacetic Acid SCHEMBL2212565 0.93 UTS2R (0.44) UTS2RHRH1CCR3MEN1KMT2A
Trifluoroacetic Acid SCHEMBL2211176 0.91 UTS2R (0.41) UTS2RHRH1CCR3MEN1KMT2A
Trifluoroacetic Acid SCHEMBL2214079 0.91 UTS2R (0.43) UTS2RHRH1CCR3MEN1KMT2A
Trifluoroacetic Acid SCHEMBL2213027 0.91 UTS2R (0.43) UTS2RHRH1CCR3MEN1KMT2A
Trifluoroacetic Acid SCHEMBL6633744 0.90 HRH3 (0.45) UTS2RCCR3MEN1KMT2AMCHR1
Trifluoroacetic Acid SCHEMBL2213092 0.90 HRH3 (0.45) UTS2RCCR3MEN1KMT2AMCHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1389616-B1 3,4-Dihalobenzylpiperidine derivatives and their medical use MITSUBISHI TANABE PHARMA CORP (JP) 2011-07-27 EP disclosed
US-7115635-B2 Benzylpiperidine compound MITSUBISHI PHARMA CORPORATION (JP) 2006-10-03 US disclosed
US-20040158071-A1 Chemokine inhibitors and stability in blood MITSUBISHI PHARMA CORPORATION (JP) 2004-08-12 US disclosed
EP-1389616-A1 NOVEL BENZYLPIPERIDINE COMPOUND Mitsubishi Pharma Corporation (JP) 2004-02-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040158071-A1 Chemokine inhibitors and stability in blood CCL2, CXCR1, CCR5 UTS2R 2154/4885HRH1 1288/4885CCR3 21/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.